vs
Side-by-side financial comparison of KINGSTONE COMPANIES, INC. (KINS) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
Vanda Pharmaceuticals Inc. is the larger business by last-quarter revenue ($57.2M vs $56.4M, roughly 1.0× KINGSTONE COMPANIES, INC.). KINGSTONE COMPANIES, INC. runs the higher net margin — 26.2% vs -246.8%, a 272.9% gap on every dollar of revenue. On growth, KINGSTONE COMPANIES, INC. posted the faster year-over-year revenue change (34.0% vs 7.6%). KINGSTONE COMPANIES, INC. produced more free cash flow last quarter ($73.1M vs $-29.5M). Over the past eight quarters, KINGSTONE COMPANIES, INC.'s revenue compounded faster (25.6% CAGR vs 9.8%).
Kingstone Companies, Inc., headquartered in Kingston, New York, provides property and casualty insurance products through its subsidiary, Kingstone Insurance Company. It places contracts with the third-party licensed premium finance company through its subsidiary Payments, Inc., a NYS licensed Insurance Premium Finance Company. Kingstone Insurance Company was ranked #1 of the 81 insurers rated by the Professional Insurance Agents Association in its 2010 Company Performance Survey. The company...
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
KINS vs VNDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $56.4M | $57.2M |
| Net Profit | $14.8M | $-141.2M |
| Gross Margin | — | — |
| Operating Margin | 32.7% | -70.5% |
| Net Margin | 26.2% | -246.8% |
| Revenue YoY | 34.0% | 7.6% |
| Net Profit YoY | 171.4% | -2774.3% |
| EPS (diluted) | $1.09 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $56.4M | $57.2M | ||
| Q3 25 | $55.7M | $56.3M | ||
| Q2 25 | $52.3M | $52.6M | ||
| Q1 25 | $50.5M | $50.0M | ||
| Q4 24 | $42.1M | $53.2M | ||
| Q3 24 | $40.8M | $47.7M | ||
| Q2 24 | $36.5M | $50.5M | ||
| Q1 24 | $35.8M | $47.5M |
| Q4 25 | $14.8M | $-141.2M | ||
| Q3 25 | $10.9M | $-22.6M | ||
| Q2 25 | $11.3M | $-27.2M | ||
| Q1 25 | $3.9M | $-29.5M | ||
| Q4 24 | $5.4M | $-4.9M | ||
| Q3 24 | $7.0M | $-5.3M | ||
| Q2 24 | $4.5M | $-4.5M | ||
| Q1 24 | $1.4M | $-4.1M |
| Q4 25 | 32.7% | -70.5% | ||
| Q3 25 | 24.6% | -55.6% | ||
| Q2 25 | 27.1% | -73.2% | ||
| Q1 25 | 9.3% | -82.0% | ||
| Q4 24 | 15.9% | -19.3% | ||
| Q3 24 | 22.3% | -23.1% | ||
| Q2 24 | 15.7% | -20.1% | ||
| Q1 24 | 5.0% | -19.5% |
| Q4 25 | 26.2% | -246.8% | ||
| Q3 25 | 19.5% | -40.1% | ||
| Q2 25 | 21.5% | -51.7% | ||
| Q1 25 | 7.7% | -58.9% | ||
| Q4 24 | 12.9% | -9.2% | ||
| Q3 24 | 17.1% | -11.2% | ||
| Q2 24 | 12.4% | -9.0% | ||
| Q1 24 | 4.0% | -8.7% |
| Q4 25 | $1.09 | $-2.40 | ||
| Q3 25 | $0.74 | $-0.38 | ||
| Q2 25 | $0.78 | $-0.46 | ||
| Q1 25 | $0.27 | $-0.50 | ||
| Q4 24 | $0.44 | $-0.09 | ||
| Q3 24 | $0.55 | $-0.09 | ||
| Q2 24 | $0.37 | $-0.08 | ||
| Q1 24 | $0.12 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $84.9M |
| Total DebtLower is stronger | $4.4M | — |
| Stockholders' EquityBook value | $122.7M | $327.2M |
| Total Assets | $453.4M | $488.9M |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $84.9M | ||
| Q3 25 | — | $70.0M | ||
| Q2 25 | — | $81.0M | ||
| Q1 25 | — | $111.8M | ||
| Q4 24 | — | $102.3M | ||
| Q3 24 | — | $100.5M | ||
| Q2 24 | — | $103.0M | ||
| Q1 24 | — | $125.2M |
| Q4 25 | $4.4M | — | ||
| Q3 25 | $4.8M | — | ||
| Q2 25 | $5.1M | — | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $11.2M | — | ||
| Q3 24 | $17.3M | — | ||
| Q2 24 | $25.3M | — | ||
| Q1 24 | $25.3M | — |
| Q4 25 | $122.7M | $327.2M | ||
| Q3 25 | $107.7M | $466.0M | ||
| Q2 25 | $94.9M | $486.3M | ||
| Q1 25 | $82.2M | $511.4M | ||
| Q4 24 | $66.7M | $538.5M | ||
| Q3 24 | $59.7M | $541.2M | ||
| Q2 24 | $40.8M | $542.5M | ||
| Q1 24 | $35.7M | $544.0M |
| Q4 25 | $453.4M | $488.9M | ||
| Q3 25 | $428.6M | $601.1M | ||
| Q2 25 | $393.4M | $624.7M | ||
| Q1 25 | $385.4M | $631.9M | ||
| Q4 24 | $374.9M | $656.2M | ||
| Q3 24 | $347.0M | $645.1M | ||
| Q2 24 | $319.8M | $651.4M | ||
| Q1 24 | $318.3M | $652.7M |
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.05× | — | ||
| Q1 25 | 0.07× | — | ||
| Q4 24 | 0.17× | — | ||
| Q3 24 | 0.29× | — | ||
| Q2 24 | 0.62× | — | ||
| Q1 24 | 0.71× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.9M | $-29.4M |
| Free Cash FlowOCF − Capex | $73.1M | $-29.5M |
| FCF MarginFCF / Revenue | 129.5% | -51.6% |
| Capex IntensityCapex / Revenue | 5.0% | 0.2% |
| Cash ConversionOCF / Net Profit | 5.14× | — |
| TTM Free Cash FlowTrailing 4 quarters | $124.0M | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.9M | $-29.4M | ||
| Q3 25 | $25.9M | $-31.6M | ||
| Q2 25 | $9.3M | $-15.3M | ||
| Q1 25 | $17.9M | $-33.1M | ||
| Q4 24 | $57.9M | $-1.8M | ||
| Q3 24 | $21.7M | $-14.6M | ||
| Q2 24 | $7.1M | $-6.9M | ||
| Q1 24 | $6.1M | $7.6M |
| Q4 25 | $73.1M | $-29.5M | ||
| Q3 25 | $25.3M | $-31.8M | ||
| Q2 25 | $8.7M | $-15.6M | ||
| Q1 25 | $17.0M | $-33.6M | ||
| Q4 24 | $55.6M | $-2.0M | ||
| Q3 24 | $21.0M | $-14.7M | ||
| Q2 24 | $6.6M | $-7.0M | ||
| Q1 24 | $5.6M | $7.6M |
| Q4 25 | 129.5% | -51.6% | ||
| Q3 25 | 45.4% | -56.5% | ||
| Q2 25 | 16.6% | -29.6% | ||
| Q1 25 | 33.7% | -67.1% | ||
| Q4 24 | 132.1% | -3.8% | ||
| Q3 24 | 51.6% | -30.9% | ||
| Q2 24 | 18.1% | -13.9% | ||
| Q1 24 | 15.5% | 15.9% |
| Q4 25 | 5.0% | 0.2% | ||
| Q3 25 | 1.2% | 0.3% | ||
| Q2 25 | 1.1% | 0.6% | ||
| Q1 25 | 1.7% | 0.9% | ||
| Q4 24 | 5.6% | 0.4% | ||
| Q3 24 | 1.7% | 0.3% | ||
| Q2 24 | 1.4% | 0.2% | ||
| Q1 24 | 1.5% | 0.0% |
| Q4 25 | 5.14× | — | ||
| Q3 25 | 2.38× | — | ||
| Q2 25 | 0.82× | — | ||
| Q1 25 | 4.60× | — | ||
| Q4 24 | 10.65× | — | ||
| Q3 24 | 3.12× | — | ||
| Q2 24 | 1.58× | — | ||
| Q1 24 | 4.27× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KINS
Segment breakdown not available.
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
